文献速递胸部CT

间质性肺疾病的量化评估:来自AJR定量影像学特别系列

Quantification of Interstitial Lung Diseases, From the AJR Special Series on Quantitative Imaging.
PubMed 文献 · AJR Am J Roentgenol · 2025-12-10

高分辨率CT在间质性肺疾病的诊断和监测中起重要作用,但视觉评估纤维化范围存在主观性且观察者间一致性仅为中等。本综述聚焦定量CT技术,介绍其在定义疾病严重程度、预后和纵向进展中的作用,并涵盖已确诊疾病和临床前间质异常。机器学习纹理分析显示纤维化范围与生理指标稳健相关,并与疾病进展或死亡风险强相关。

要点

  • 视觉评估CT纤维化范围是死亡的独立预测因子,但主观性强,观察者间一致性仅为中等。
  • 基于机器学习的纹理分析定量CT纤维化范围与生理指标稳健相关,并与进展或死亡风险强相关。
  • 在特发性肺纤维化中,纵向纤维化严重度增加与进展和死亡风险增加相关。

核心结论

  • 定量CT技术可用于间质性肺疾病的严重度、预后和纵向进展评估,在已确诊疾病和临床前间质异常中均有价值。

研究设计与样本

  • 综述,聚焦间质性肺疾病的定量CT技术,描述临床需求及传统视觉评估与定量CT方法的作用。

关键影像表现/征象

  • 高分辨率CT可无创显示并分类肺损伤模式,并评估疾病范围。
  • 视觉估计CT纤维化肺病范围是死亡的独立预测因子,但观察者间一致性仅为中等。

临床应用与阅片要点

  • 机器学习纹理分析定量基线及系列高分辨率CT的纤维化范围,与生理指标稳健相关,并与多种纤维化间质性肺疾病的进展或死亡风险强相关。
  • 在特发性肺纤维化中,定量CT评估与生理损害及进展和死亡风险相关。
  • 纵向评估中纤维化严重度增加与进展和死亡风险增加相关,类似结果见于纤维化过敏性肺炎和结缔组织病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

High-resolution CT (HRCT) plays an important role in diagnosing and monitoring interstitial lung diseases (ILDs). Despite advances, predicting disease progression and treatment response remains challenging. HRCT enables noninvasive visualization and classification of patterns of lung injury and assessment of disease extent. Visual estimation of CT extent of fibrotic lung disease is an independent predictor of mortality and progression but is subjective, with only modest interobserver agreement for radiologic interpretation of ILD. Machine learning-based textural analyses of fibrosis extent on baseline and serial HRCT scans show robust correlations with physiologic measures and strong association with risk of disease progression or mortality across various fibrosing ILDs. In idiopathic pulmonary fibrosis, quantitative CT (QCT) assessment is associated with physiologic impairment and risk of progression and death, and increasing severity of fibrosis on longitudinal evaluation is associated with increased risk of progression and death. Similar results have been noted for fibrotic hypersensitivity pneumonitis and connective tissue disease. This review focuses on QCT techniques for ILDs. We describe the clinical need for quantification of lung disease and illustrate the role of conventional visual evaluation and of QCT approaches in defining disease severity, prognosis, and longitudinal progression, both in established disease and in preclinical interstitial abnormalities.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Humphries SM, Chung A, Swigris JJ, et al. Quantification of Interstitial Lung Diseases, From the AJR Special Series on Quantitative Imaging. AJR Am J Roentgenol. 2025. PMID: 39564907. doi:10.2214/AJR.24.32053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。